Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
2 Unstoppable Growth Stocks to Buy While Share Prices Are Low: https://g.foolcdn.com/editorial/images/727549/a-person-looking-at-a-chart-on-their-laptop.jpg
2 Unstoppable Growth Stocks to Buy While Share Prices Are Low

A look at the facts will often reveal businesses that are poised for future growth and/or show no signs of slowing down. The stocks for these types of businesses tend to be particularly valuable to

Which Healthcare Company Will Be the First to Get to a $1 Trillion Market Cap?: https://g.foolcdn.com/editorial/images/727540/a-doctor-looking-at-a-tablet-with-another-person.jpg
Which Healthcare Company Will Be the First to Get to a $1 Trillion Market Cap?

There are several healthcare companies with market caps in the hundreds of billions. However, there isn't one among this group that is approaching the $1 trillion mark just yet. There are four

Why 2023 Could Be a Tough Year for AbbVie Stock: https://g.foolcdn.com/editorial/images/727547/a-couple-using-a-laptop-and-reviewing-documents.jpg
Why 2023 Could Be a Tough Year for AbbVie Stock

At first glance, AbbVie (NYSE: ABBV) might look like a stock that's reasonably valued or even a cheap buy. It even has the added bonus of an attractive dividend yield of 3.7%. But there are some

EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement  of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St
Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors: https://mms.businesswire.com/media/20230321005381/en/1743191/5/Heidi_and_Hayley_Press_Release_Image.jpg
Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all

Waters stellt die nächste Generation des HPLC-Systems Alliance iS vor, das die Zahl der üblichen Laborfehler um bis zu 40 % reduzieren soll: https://mms.businesswire.com/media/20230320005171/de/1741905/5/WATERS_ALLIANCE_iS_Beauty02_LHS_Bottles_Transparent_300_dpi_ISS_A.jpg
Waters stellt die nächste Generation des HPLC-Systems Alliance iS vor, das die Zahl der üblichen Laborfehler um bis zu 40 % reduzieren soll


PITTCON 2023 Die Waters Corporation (NYSE:WAT) stellte heute mit Alliance iS ihr intelligentes HPLC-System der nächsten Generation vor. Es wurde entwickelt, um Compliance-Risiken durch neue

Die neue Battery Cycler Microcalorimeter Solution von Waters beschleunigt Praxistests von Monaten auf Wochen: https://mms.businesswire.com/media/20230320005272/de/1742096/5/TAM-Cell-Cycler-Battery_Lab-tech-loading-18650-detail.jpg
Die neue Battery Cycler Microcalorimeter Solution von Waters beschleunigt Praxistests von Monaten auf Wochen


PITTCON 2023 — Die Waters Corporation (NYSE:WAT) kündigte heute eine neue Battery Cycler Microcalorimeter Solution ihrer TA Instruments™ Division an, die eine hochauflösende Charakterisierung von

Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks: https://mms.businesswire.com/media/20230320005271/en/1742096/5/TAM-Cell-Cycler-Battery_Lab-tech-loading-18650-detail.jpg
Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks


PITTCON 2023 — Waters Corporation (NYSE:WAT) today announced a new Battery Cycler Microcalorimeter Solution from its TA Instruments™ Division for high-resolution characterization of battery cells

Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors: https://mms.businesswire.com/media/20230320005167/en/1741905/5/WATERS_ALLIANCE_iS_Beauty02_LHS_Bottles_Transparent_300_dpi_ISS_A.jpg
Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors


PITTCON 2023 Waters Corporation (NYSE:WAT) today introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error

EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick: https://mms.businesswire.com/media/20230216005855/en/1716502/5/Frederick_Oligo_Facility_Expansion_Rendering_2023.jpg
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick


Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent’s $725 million investment to double

EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain highhttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
EQS-Adhoc: Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24691/Logo_der_Bayer_AG.svg.png
EQS-Adhoc: Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
EQS-Adhoc: Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System: https://mms.businesswire.com/media/20230207005121/en/1705896/5/Warriors_On_Set_0464.jpg
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the company’s second Super Bowl commercial, which announces the US

New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management: https://mms.businesswire.com/media/20230125005060/en/1694520/5/MicrosoftTeams-image_%2849%29.jpg
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management


Waters Corporation (NYSE:WAT) today announced waters_connect™ System Monitoring, a new Software-as-a-Service (SaaS) application that enables laboratory managers and analysts to monitor the

Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program: https://mms.businesswire.com/media/20230117005450/en/1687296/5/Dexcom_English_Release_Photo.jpg
Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program


Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 rtCGM System on the Non-Insured Health Benefits

Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics: https://mms.businesswire.com/media/20230109005201/en/1679772/5/Frederick_Oligo_Facility_Expansion_Rendering_2023.jpg
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics


Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1

Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience: https://mms.businesswire.com/media/20221212005091/en/1660908/5/Brad_Cooking3.jpg
Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience


Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (rtCGM), announced today its partnership with Green Shield and The Health Depot digital pharmacy to provide Green

EQS-News: Carl Zeiss Meditec remains on growth course in fiscal year 2021/22 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
EQS-News: Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.: https://mms.businesswire.com/media/20221208005302/en/1658991/5/Dinner.jpg
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation Dexcom G7 Continuous

EQS-Adhoc: Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company
EQS-Adhoc: Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company